» Articles » PMID: 18592380

Screening of Venlafaxine Hydrochloride for Transdermal Delivery: Passive Diffusion and Iontophoresis

Overview
Publisher Springer
Specialty Pharmacology
Date 2008 Jul 2
PMID 18592380
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the study was to investigate in vitro transdermal delivery of venlafaxine hydrochloride across the pigskin by passive diffusion and iontophoresis. For passive diffusion, experiments were carried out in Franz diffusion cell whereas for iontophoretic permeation, the diffusion cell was modified to contain both the donor and return electrode on the same side of skin. Anodal iontophoresis was carried out using a current density of 0.5 mA/cm(2). Donor concentrations used were 585.5 mg/ml (saturated solution) and 100 mg/ml. Experiments initially performed to determine the transport efficiency of venlafaxine ions showed promising results. Iontophoresis increased the permeation rate at both concentration levels over their passive counterparts (P < 0.01), but surprisingly higher steady-state flux was obtained from lower donor drug load (P < 0.01). The favorable pH of the unsaturated solutions is suggested to be the cause for this effect. Mild synergistic effect was observed when iontophoresis was carried out incorporating peppermint oil in the donor but the same was not found in passive diffusion. Highest steady-state flux obtained in the experiment was 3.279 mumol/cm(2)/h when peppermint oil (0.1%) was included in the donor. As the maintenance requirement of venlafaxine hydrochloride is approximately 9.956 mumol/h, the results suggested that the drug is a promising candidate for iontophoretic delivery.

Citing Articles

Application of mathematical modelling to alginate chitosan polyelectrolyte complexes for the prediction of system behavior with Venlafaxine HCl as a model charged drug.

Ibrahim H, Sorour R, Salah Ad-Din I Saudi Pharm J. 2022; 30(10):1507-1520.

PMID: 36387334 PMC: 9649359. DOI: 10.1016/j.jsps.2022.07.013.


Venlafaxine HCl Encapsulated in Niosome: Green and Eco-friendly Formulation for the Management of Pain.

Hashemi S, Enayatifard R, Akbari J, Saeedi M, Seyedabadi M, Morteza-Semnani K AAPS PharmSciTech. 2022; 23(5):149.

PMID: 35595933 DOI: 10.1208/s12249-022-02299-5.


Synergistic Effect and Mechanism of Cineole and Terpineol on In-vitro Transdermal Delivery of Huperzine A from Microemulsions.

Shi J, Cong W, Wang Y, Liu Q, Luo G Iran J Pharm Res. 2013; 12(2):271-80.

PMID: 24250600 PMC: 3813235.


5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model.

Cheng M, He B, Wan T, Zhu W, Han J, Zha B PLoS One. 2012; 7(10):e47115.

PMID: 23077553 PMC: 3471936. DOI: 10.1371/journal.pone.0047115.


In vitro and In vivo characterization of the transdermal delivery of sertraline hydrochloride Films.

Vijaya R, Ruckmani K Daru. 2012; 19(6):424-32.

PMID: 23008688 PMC: 3436079.


References
1.
Al-Khalili M, Meidan V, Michniak B . Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. AAPS PharmSci. 2003; 5(2):E14. PMC: 2751522. DOI: 10.1208/ps050214. View

2.
Hawkins G, Reifenrath W . Influence of skin source, penetration cell fluid, and partition coefficient on in vitro skin penetration. J Pharm Sci. 1986; 75(4):378-81. DOI: 10.1002/jps.2600750411. View

3.
Amnuaikit C, Ikeuchi I, Ogawara K, Higaki K, Kimura T . Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm. 2005; 289(1-2):167-78. DOI: 10.1016/j.ijpharm.2004.11.007. View

4.
Panchagnula R, Bokalial R, Sharma P, Khandavilli S . Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int J Pharm. 2005; 293(1-2):213-23. DOI: 10.1016/j.ijpharm.2005.01.004. View

5.
Mudry B, Guy R, Begona Delgado-Charro M . Transport numbers in transdermal iontophoresis. Biophys J. 2006; 90(8):2822-30. PMC: 1414545. DOI: 10.1529/biophysj.105.074609. View